DRTS on Nasdaq
Alpha Tau Medical Ltd.
Price unavailable
Last updated Oct 16, 2026.
Overview
-$42.6MNet income, fiscal 20252
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Financial statements
No quarterly figures reported.
Every line of the income statement in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Research and development, net | $32.1M | $27.0M | $26.4M |
| Marketing expenses | $1.9M | $2.3M | $1.9M |
| General and administrative | $8.4M | $6.7M | $7.3M |
| Total operating loss | $42.3M | $36.0M | $35.7M |
| Financial (income) expenses, net | $218.0K | -$4.3M | -$6.5M |
| Loss before taxes on income | $42.5M | $31.7M | $29.1M |
| Tax on income | $121.0K | $6.0K | $16.0K |
| Net loss | $42.6M | $31.8M | $29.2M |
| Net comprehensive loss | $42.6M | $31.8M | $29.2M |
| Net loss per share, basic (in Dollars per share) | -$0.53 | -$0.45 | -$0.42 |
| Net loss per share, diluted (in Dollars per share) | -$0.53 | -$0.45 | -$0.42 |
| Weighted-average shares used in computing net loss per share, basic (in Shares) | 80.6M shares | 69.9M shares | 69.4M shares |
| Weighted-average shares used in computing net loss per share, diluted (in Shares) | 80.6M shares | 69.9M shares | 69.4M shares |
No quarterly figures reported.
Every line of the balance sheet in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $12.2M | $13.7M | |
| Short-term deposits | $60.9M | $45.9M | |
| Restricted deposits | $3.8M | $3.3M | |
| Prepaid expenses and other receivables | $1.4M | $1.4M | |
| Total current assets | $78.3M | $64.2M | |
| Long-term prepaid expenses | $479.0K | $432.0K | |
| Property and equipment, net | $19.7M | $13.9M | |
| Operating lease right-of-use assets | $7.2M | $7.6M | |
| Total long-term assets | $27.4M | $22.0M | |
| Total assets | $105.7M | $86.2M | |
| Trade payables | $3.9M | $3.5M | |
| Other payables and accrued expenses | $5.5M | $4.1M | |
| Current maturities of operating lease liabilities | $1.1M | $1.0M | |
| Total current liabilities | $10.5M | $8.7M | |
| Long-term loan | $6.4M | $5.6M | |
| Warrants liability | $5.4M | $3.3M | |
| Operating lease liabilities | $6.2M | $6.0M | |
| Deferred tax liability | $97.0K | ||
| Total long-term liabilities | $18.0M | $14.9M | |
| Total liabilities | $28.6M | $23.5M | |
| Additional paid-in capital | $267.2M | $210.2M | |
| Accumulated deficit | -$190.1M | -$147.5M | |
| Total shareholders equity | $77.1M | $62.7M | $84.5M |
| Total liabilities and shareholders equity | $105.7M | $86.2M | |
| Ordinary shares, authorized (in Shares) | 362.1M shares | 362.1M shares | |
| Ordinary shares, issued (in Shares) | 88.0M shares | 70.4M shares | |
| Ordinary shares, outstanding (in Shares) | 88.0M shares | 70.4M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss | -$42.6M | -$31.8M | -$29.2M |
| Depreciation | $1.2M | $1.1M | $1.1M |
| Loss from property and equipment disposals | $35.0K | ||
| Share-based compensation | $10.6M | $9.9M | $7.9M |
| Non-cash financial expenses (income), net | -$245.0K | $40.0K | $1.7M |
| Decrease (increase) in prepaid expenses and other receivables | -$21.0K | -$558.0K | $281.0K |
| (Increase) decrease in long-term prepaid expenses | -$47.0K | $39.0K | -$80.0K |
| Change in the fair value of warrants liabilities | $2.0M | -$259.0K | -$2.0M |
| Increase in trade payables | $337.0K | $965.0K | $1.1M |
| Increase in other payables and accrued expenses | $1.1M | $659.0K | $1.2M |
| Increase in deferred taxes liability | $97.0K | ||
| Change in operating lease liabilities | -$23.0K | -$726.0K | -$809.0K |
| Change in operating lease right-of-use assets | $817.0K | $789.0K | $729.0K |
| Net cash used in operating activities | -$26.7M | -$19.8M | -$18.0M |
| Investment in short-term deposits | -$70.5M | -$125.1M | -$163.6M |
| Investment in restricted deposit | -$103.0K | -$3.2M | |
| Proceeds from short-term deposits | $56.0M | $148.2M | $191.9M |
| Purchase of property and equipment | -$6.1M | -$2.2M | -$6.4M |
| Net cash provided by (used in) investing activities | -$20.6M | $20.8M | $18.7M |
| Proceed from short-term loan | $5.2M | ||
| Repayment of short-term loan | -$5.2M | ||
| Proceeds from long-term loan | $5.2M | ||
| Proceeds from issuance of Ordinary shares, net | $45.5M | ||
| Proceeds from exercise of options | $272.0K | $25.0K | $49.0K |
| Net cash provided by financing activities | $45.8M | $25.0K | $5.3M |
| Effect of exchange rate changes on cash and cash equivalents | -$21.0K | $57.0K | -$50.0K |
| Increase (decrease) in cash and cash equivalents | -$1.5M | $1.1M | $6.0M |
| Income taxes paid | $4.0K | $5.0K | $16.0K |
| Interest received | $2.8M | $4.4M | $6.2M |
| Interest paid | $381.0K | $321.0K | $52.0K |
| Operating lease liabilities arising from obtaining right of use assets | $422.0K | $35.0K | $3.3M |
| Purchases of property and equipment in exchange for Ordinary shares | $675.0K | ||
| Purchases of property and equipment in other payables and accrued expenses | $244.0K |
Recent filings
- Aug 31, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Aug 25, 20264 PRIMARY DOCUMENT
- Aug 21, 2026144
- Aug 12, 20264 PRIMARY DOCUMENT
- Aug 10, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Aug 10, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Jul 21, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Jul 15, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Jul 7, 20264 PRIMARY DOCUMENT
- Jul 6, 20264 PRIMARY DOCUMENT
- Jul 6, 2026144
- Jul 2, 2026144
- Jul 2, 20264 PRIMARY DOCUMENT
- Jul 1, 20264 PRIMARY DOCUMENT
- Jun 30, 2026144
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7